search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
FACI LIT I E S MANAGEMENT


A review of the auditing frequency should be undertaken, and consideration given to minimising activity within affected areas. An agreed monitoring protocol for use during the episode should be drawn up and documented for future reference. This approach provides assurance that standards are being met while supporting organisations to ensure the safety of their employees and minimise the potential for spread of infection. Audits are a snapshot in time and are designed to provide assurance around the level of cleanliness within a given functional risk category and it is our collective responsibility to ensure they are meaningful, effective and we don’t create an industry out of the process.


Audits must be consistent in their approach, have clear accountability and responsibility to close out actions and involve key stakeholders. Consideration should be given to ensuring that joint audits are performed wherever possible to provide a rounded perspective as well as multi-level assurance of the standards being achieved. Importantly, if the purpose of audit is to improve patient care, we must consider the patient perspective and what’s more assuring to them from any audit process. The addition of the star rating as part of the new National standards aims to provide assurance to patients, but will it have the desired effect?


Harnessing the power of service user involvement


Another key strategy relates to the ability of organisations to harness learnings from COVID-19 and the impact on infection prevention as a tool to empower patients to be more involved in strategies to prevent the spread of infection. With any new standards or policies, it’s a key first step to put yourself in the shoes of the patient and think about what they’ll be experiencing because of the changes you make.


Award Winning ShuttlePouch™ Safely Send Your Biological Samples


Listening to service users and patients in any development or design is invaluable. Taking those interesting insights and ideas means what you eventually roll out has been created with your key users in mind, which has huge benefits to NHS staff and patients alike.


Because of COVID-19, people have a better understanding of why we do what we do and the practices we put in place to keep people safe in a healthcare setting, and we have an opportunity to harness


INNOVATIVE, UNIQUE, SECONDARY PACKAGING SOLUTION FOR SWAB, BLOOD & OTHER SAMPLE TUBES


■ Leak Proof Pouch ■ Designed to carry a single 95kPa pressure differential certified swab, blood or any similar sized specimen tube


■ Also available for urine tubes


■ Made from up to 83% less plastic than other pouches


■ Contains absorbent material


■ Provides a complete, compliant UN3373 solution when packed in a rigid outer transport box


Tel: 023 8048 3000 | Web: www.UN3373.co.uk DECEMBER 2021 CSJ_ShuttlePouch_Infection_Prevention_2022.indd 1 15/11/2021 13:41:39 WWW.CLINICALSERVICESJOURNAL.COM l 45





Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56